Obermeyer Wood Investment Counsel, Lllp Protagonist Therapeutics, Inc Transaction History

Obermeyer Wood Investment Counsel, Lllp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$21.79 - $32.15 $3,835 - $5,658	176 Added 1.46%	12,242 $354,000
Q4 2023 Jan 31, 2024	SELL	$14.05 - $23.44 $24,250 - $40,457	-1,726 Reduced 12.51%	12,066 $276,000
Q3 2023 Nov 08, 2023	BUY	$16.68 - $23.66 $19,682 - $27,918	1,180 Added 9.36%	13,792 $230,000
Q2 2023 Aug 04, 2023	SELL	$18.02 - $29.36 $19,389 - $31,591	-1,076 Reduced 7.86%	12,612 $348,000
Q1 2023 May 09, 2023	SELL	$10.78 - $25.38 $7,136 - $16,801	-662 Reduced 4.61%	13,688 $314,000
Q4 2022 Feb 08, 2023	SELL	$7.36 - $11.17 $7,050 - $10,700	-958 Reduced 6.26%	14,350 $156,000
Q3 2022 Dec 09, 2022	BUY	$7.86 - $11.71 $267 - $398	34 Added 0.22%	15,308 $129,000
Q2 2022 Aug 15, 2022	SELL	$7.06 - $25.52 $5.55 Million - $20.1 Million	-786,351 Reduced 98.09%	15,274 $121,000
Q1 2022 May 16, 2022	BUY	$23.34 - $36.08 $296,021 - $457,602	12,683 Added 1.61%	801,625 $19 Million
Q4 2021 Jan 31, 2022	BUY	$17.63 - $37.1 $216,020 - $454,586	12,253 Added 1.58%	788,942 $27 Million
Q3 2021 Oct 19, 2021	BUY	$12.95 - $49.69 $202,939 - $778,691	15,671 Added 2.06%	776,689 $13.8 Million
Q2 2021 Jul 29, 2021	BUY	$25.57 - $44.88 $9.59 Million - $16.8 Million	374,946 Added 97.12%	761,018 $34.2 Million
Q1 2021 May 10, 2021	BUY	$19.02 - $31.15 $7.34 Million - $12 Million	386,072 New	386,072 $10 Million

248

56.7M

76.3K

114K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $1.93B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Obermeyer Wood Investment Counsel, Lllp, based on Form 13F filings with the SEC.

Stay updated on Obermeyer Wood Investment Counsel, Lllp with notifications on news.